...
首页> 外文期刊>Glia >Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein
【24h】

Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein

机译:小胶质细胞PHOX和Mac-1对于A30P和A53T突变体α-突触核蛋白引起的增强的多巴胺能神经变性至关重要

获取原文
获取原文并翻译 | 示例
           

摘要

alpha-Synuclein, a gene whose mutations, duplication, and trip lication has been linked to autosomal dominant familial Parkinson's disease (fPD), appears to play a central role in the pathogenesis of sporadic PD (sPD) as well. Enhancement of neurodegeneration induced by mutant alpha-synuclein has been attributed to date largely to faster formation of asynuclein aggregates in neurons. Recently, we reported that microglial activation enhances wild type (WT) alpha-synucleinelicited dopaminergic neurodegeneration. In the present study, using a primary mesencephalic culture system, we tested whether mutated alpha-synuclein could activate microglia more powerfully than WT alpha-synuclein, thereby contributing to the accelerated neurodegeneration observed in fPD. The results showed that alpha-synuclein with the A30P or A53T mutations caused greater microglial activation than WT alpha-synuclein. Furthermore, the extent of microglial activation paralleled the degree of dopaminergic neurotoxicity induced by WT and mutant alpha-synuclein. Mutant alpha-synuclein also induced greater production of reactive oxygen species than WT alpha-synuclein by NADPH oxidase (PHOX), and PHOX activation was linked to direct activation of macrophage antigen-1 (Mac-1) receptor, rather than alpha-synuclein internalization via scavenger receptors. These results have, for the first time, demonstrated that microglia are also critical in enhanced neurotoxicity induced by mutant alpha-synuclein. (C) 2007 Wiley-Liss, Inc.
机译:α-突触核蛋白是一种基因,其突变,重复和跳闸与常染色体显性家族性帕金森病(fPD)相关,在散发性PD(sPD)的发病机理中似乎也起着核心作用。迄今为止,突变α-突触核蛋白诱导的神经变性的增强主要归因于神经元中突触核蛋白聚集体的更快形成。最近,我们报道了小胶质细胞激活增强了野生型(WT)α-突触核苷引起的多巴胺能神经变性。在本研究中,我们使用原发性中脑培养系统测试了突变的α-突触核蛋白是否能比WTα-突触核蛋白更有效地激活小胶质细胞,从而促进了在fPD中观察到的加速神经变性。结果表明,具有A30P或A53T突变的α-突触核蛋白比WTα-突触核蛋白引起更大的小胶质细胞活化。此外,小胶质细胞活化的程度与野生型和突变体α-突触核蛋白诱导的多巴胺能神经毒性的程度相近。 NADPH氧化酶(PHOX)突变的α-突触核蛋白还诱导了比WTα-突触核蛋白更大的活性氧生成,并且PHOX的激活与巨噬细胞抗原1(Mac-1)受体的直接激活有关,而不是与α-突触核蛋白的内在化有关。通过清道夫受体。这些结果首次证明,小胶质细胞在突变型α-突触核蛋白诱导的神经毒性增强中也很关键。 (C)2007 Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号